BioSpace News Archive

Business

Cognition Therapeutics Reports Year End 2022 Financial Results and Provides Business Update

Cognition Therapeutics, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2022, and provided a business update.

March 23, 2023
·
10 min read
Biotech Beach

Capstan Therapeutics to Participate in Upcoming Investor Conferences

Capstan Therapeutics, Inc. today announced that Capstan management will participate in the following upcoming investor conferences.

March 23, 2023
·
1 min read
Business

Xenetic Biosciences, Inc. Reports Full Year 2022 Financial Results and Provides Business Update

Xenetic Biosciences, Inc. today reported its financial results for the full year 2022 and provided a business update.

March 23, 2023
·
7 min read
Business

Palisade Bio Reports Year End 2022 Financial Results and Provides Corporate Update

Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today reported its financial results for the full year 2022 and provided a corporate update.

March 23, 2023
·
11 min read
Biotech Beach

Nexcella Announces New Positive NXC-201 Clinical Data Demonstrating 100% Complete Responses in AL Amyloidosis Patients + Additional Positive Multiple Myeloma Safety Data Demonstrating NXC-201 Outpatient CAR-T Treatment Potential

Nexcella, Inc., a subsidiary of Immix Biopharma, Inc. announced that NXC-201 treatment continues to demonstrate 100% complete hematologic responses and 100% organ response rate – cardiac, renal, liver response – in a total of 8 AL amyloidosis patients.

March 23, 2023
·
8 min read
BioForest

Chinook Therapeutics Announces Upcoming Presentations at ISN World Congress of Nephrology 2023

Chinook Therapeutics, Inc. today announced presentations at the ISN World Congress of Nephrology 2023 from March 30 – April 2, 2023 in Bangkok, Thailand.

March 23, 2023
·
3 min read
Pharm Country

Vaccinex, Inc. to Present at the 2023 AAIC Advancements: Immunity ConferenceMarch 24th presentation to highlight learnings related to pepinemab’s mechanism of action in both Huntington’s Disease and Alzheimer’s Disease

Vaccinex, Inc. today announced its COO and Senior Vice President, Discovery and Translational Medicine, Elizabeth Evans, PhD, will be making a podium presentation at the AAIC Advancements: Immunity conference.

March 23, 2023
·
4 min read
Drug Development

Biomea Fusion to Host Conference Call and Webcast to Discuss Initial Phase II Clinical Data for BMF-219 in Subjects with Type 2 Diabetes on March 28th, 2023 at 8:30 a.m. ET

Biomea Fusion, Inc. today announced that it will host a conference call and webcast to discuss the initial clinical data from the first two cohorts of the Phase II portion of COVALENT-111 on Tuesday, March 28th at 8:30 am ET.

March 23, 2023
·
6 min read
BioMidwest

Ocuphire Announces APX3330 and Nyxol® Data Presentations at ARVO 2023 Annual Meeting

Ocuphire Pharma, Inc. today announced five presentations featuring results from the Company’s recently completed trials of APX3330 and Nyxol at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, to take place in New Orleans, LA from April 23 to April 27, 2023.

March 23, 2023
·
4 min read
Business

Establishment Labs Announces First Mia Femtech™ Partners in Europe and Second Partner Chain in Japan

Establishment Labs Holdings Inc. today announced it has entered into agreements with four partners in Europe and a second partner chain in Japan for Mia Femtech™ (“Mia®”).

March 23, 2023
·
6 min read